Observational studyUrolithiasis2026
Clinical features of hypocitraturic kidney stone formers: an observational and retrospective real-life study in an Italian kidney stone center.
Observational study in Urolithiasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low urinary excretion of citrate is a risk factor for calcium nephrolithiasis, but clinical features of hypocitraturic stone formers remain unclear. Therefore, the present study explored clinical characteristics of hypocitraturic stone formers. It retrospectively analysed clinical characteristics of hypocitraturic patients in a series of 668 adult stone formers refering to a stone outpatient clinic in Milan. Hypocitraturic stone formers (n = 227, 34%) had lower excretion of calcium, phosphate, uric acid, sodium, and potassium than normocitraturic patients. Considering quartiles of citrate excretion, patients in the lowest quartile had lower potassium excretion than patients in the other quartiles, lower calcium, sodium and phosphate excretion and serum urate than patients in the two highest quartiles. During a 2-year follow-up stone recurrence occurred in 127 patients (19%) and was more frequent in hypocitraturic than normocitraturic patients (OR 1.6, 95%CI 1.06–2.34, p = 0.024). Logistic regression showed that the highest risk of stone recurrence was in patients who were hypercalciuric, hyperoxaluric and hypocitraturic (OR 9.3, 95%CI 2–44.6, p = 0.005; stone formers without defects as reference group) and in patients having hyperoxaluria and hypocitraturia (OR 4.2, 95%CI 1.2–14.6, p = 0.024). These findings were confirmed in patients treated with citrate supplements during the follow-up. In conclusion, hypocitraturia is a frequent risk factor for nephrolithiasis and may be associated with low excretion of the other substances involved in the lithogenesis. The association of hypocitraturia with hypercalciuria and/or hyperoxaluria is indicative of a marked risk of stone recurrence during a follow-up of two years.
Indexed as
Identifiers
41543535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.